Would You Buy Generic AI? | Tomasz Tunguz

Source: original

Would You Buy Generic AI?

March 2, 2026

AI data startups

Kirkland ibuprofen is the same molecule as Advil. Same dosage, same FDA requirements, same therapeutic effect.1 It costs 80% less.

AI has its generic drug moment. DeepSeek V3 matches GPT-5.2 on most benchmarks.2 It costs 90% less. OpenAI & Anthropic generated $22 billion in 2025.3 Chinese AI labs generated $1.8 billion.4 The ratio : 12:1.

AI Lab Revenue 2025 - US vs China

Pricing explains the gap. Chinese AI API prices collapsed 90% in 2024.5 US frontier models average $3.38 per million input tokens. Chinese models average $0.48.

Company | Model | Input ($/1M tokens) | Output ($/1M tokens)

Anthropic | Claude Opus 4.6 | 5.00 | 25.00 OpenAI | GPT-5.2 | 1.75 | 14.00 Zhipu | GLM-5 | 1.00 | 3.20 Minimax | M2.5 | 0.30 | 1.20 DeepSeek | V3 | 0.14 | 0.28

OpenAI processes roughly 8.6 trillion tokens per day.6 Chinese labs likely match or exceed this volume. The 12:1 revenue gap isn’t usage. It’s price.

Three forces drive Chinese prices down.

First, distillation commoditizes capability. Anthropic accused DeepSeek, Minimax & Moonshot AI of conducting “industrial-scale campaigns” to extract knowledge from Claude.7 OpenAI made similar accusations to Congress.8

Second, hyperscalers subsidize AI to win cloud customers. Alibaba Cloud cut LLM pricing by up to 97%.9 Baidu, ByteDance & Tencent spent $1.1B on AI subsidies during Chinese New Year 2026 alone.10

Third, DeepSeek set the floor. They trained V3 for $6 million versus OpenAI’s $100 million+ for GPT-4,11 price at $0.14 per million input tokens & hit $220 million ARR with 122 employees.

In the US, Chinese models also price at a discount. Together AI charges $1.25 per million input tokens for DeepSeek V3.12 DeepInfra offers $0.21 per million.13 DeepSeek’s own API charges $0.14 - 12x less than GPT-5.2.14

DeepSeek V3 Pricing by Provider vs OpenAI GPT-5.2

Pharma companies spend billions developing a molecule, then enjoy 20 years of patent protection to recoup R&D costs before generics flood the market. AI follows the same pattern - massive R&D costs upfront, then commoditization. But the timeline is compressed.

In pharma, the generic window opens after two decades. In AI, it opens in weeks. DeepSeek V3 costs $0.14 per million tokens. GPT-5.2 costs $1.75. Same capability. Different label. The 90% discount isn’t coming. It’s here.

The question : how to protect an asset that takes hundreds of millions to develop when it can be copied in a month? Sources 1. Generic vs Brand Name Ibuprofen - CBS News ↩︎

  1. DeepSeek-V3 Technical Report - arXiv ↩︎

  2. OpenAI Revenue - The Information, Anthropic Revenue - Bloomberg ↩︎

  3. Chinese AI lab revenues (trailing 12 months as of mid-2025) : 4Paradigm $834M - KrASIA, SenseTime $610M - Yahoo Finance, DeepSeek $220M - Business of Apps, [Minimax $79M, Zhipu $70M - industry estimates] ↩︎

  4. China AI Price War - South China Morning Post ↩︎

  5. OpenAI Token Volume - PYMNTS ↩︎

  6. Anthropic Distillation Claims - CNBC ↩︎

  7. OpenAI DeepSeek Memo - Bloomberg ↩︎

  8. Alibaba 97% Price Cuts - SiliconAngle ↩︎

  9. Chinese New Year AI Spending - Morgan Stanley ↩︎

  10. GPT-4 Training Cost - TechRadar ↩︎

  11. Together AI Pricing ↩︎

  12. DeepInfra Pricing - Artificial Analysis ↩︎

  13. DeepSeek Official Pricing ↩︎